Status:

UNKNOWN

Efficacy of Retinal Nerve Fiber Layer (RNFL) / Retinal Thickness Ratio by Cirrus OCT Utilizing Spectral -Domain Technology as a Diagnostic Predictor of Glaucoma

Lead Sponsor:

Yonsei University

Conditions:

Glaucoma

Myopia

Eligibility:

All Genders

10-90 years

Brief Summary

Glaucoma is presumed to be an axonal disease which starts at the lamina cribrosa. This assumption has led to the monitoring of the retinal nerve fiber layer thickness for the diagnosis and monitoring ...

Eligibility Criteria

Inclusion

  • Primary open angle glaucoma
  • Myopia
  • Myopia with evidence of glaucoma
  • Normal controls

Exclusion

  • Evidence of retinal disease
  • BCVA \< 0.4
  • Secondary glaucoma due to intraocular inflammation
  • Lens induced glaucoma
  • Tumor induced glaucoma
  • Neovascular glaucoma

Key Trial Info

Start Date :

October 1 2008

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 1 2008

Estimated Enrollment :

400 Patients enrolled

Trial Details

Trial ID

NCT00772993

Start Date

October 1 2008

End Date

December 1 2008

Last Update

October 16 2008

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Institute of Vision Research, Department of Ophthalmology, Severance Hospital, Yonsei University School of Medicine

Seoul, South Korea, 120-752